The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADAPTIVE BIOTECHNOLOGIES COR | COM | 00650F109 | 48,946 | 1,440,000 | SH | SOLE | 1,440,000 | 0 | 0 | ||
AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 99,915 | 2,165,000 | SH | SOLE | 2,165,000 | 0 | 0 | ||
ALECTOR INC | COM | 014442107 | 37,653 | 1,650,000 | SH | SOLE | 1,650,000 | 0 | 0 | ||
ALLOGENE THERAPEUTICS INC | COM | 019770106 | 53,970 | 2,100,000 | SH | SOLE | 2,100,000 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 188,810 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
BEAM THERAPEUTICS INC | COM | 07373V105 | 71,246 | 818,820 | SH | SOLE | 818,820 | 0 | 0 | ||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 54,450 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
BIOLIFE SOLUTIONS INC | COM NEW | 09062W204 | 320,205 | 7,566,292 | SH | SOLE | 7,566,292 | 0 | 0 | ||
BERKELEY LTS INC | COM | 084310101 | 3,912 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 159,356 | 1,550,000 | SH | SOLE | 1,550,000 | 0 | 0 | ||
CAREDX INC | COM | 14167L103 | 75,622 | 1,193,335 | SH | SOLE | 1,193,335 | 0 | 0 | ||
CODEXIS INC | COM | 192005106 | 100,716 | 4,330,000 | SH | SOLE | 4,330,000 | 0 | 0 | ||
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 29,822 | 266,430 | SH | SOLE | 266,430 | 0 | 0 | ||
DERMTECH INC | COM | 24984K105 | 56,032 | 1,745,000 | SH | SOLE | 1,745,000 | 0 | 0 | ||
DENALI THERAPEUTICS INC | COM | 24823R105 | 85,765 | 1,700,000 | SH | SOLE | 1,700,000 | 0 | 0 | ||
EXACT SCIENCES CORP | COM | 30063P105 | 225,280 | 2,360,186 | SH | SOLE | 2,360,186 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 201,518 | 3,400,000 | SH | SOLE | 3,400,000 | 0 | 0 | ||
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 30,084 | 1,115,455 | SH | SOLE | 1,115,455 | 0 | 0 | ||
FOGHORN THERAPEUTICS INC | COM | 344174107 | 2,995 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | ||
GENERATION BIO CO | COM | 37148K100 | 33,200 | 1,324,275 | SH | SOLE | 1,324,275 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 49,049 | 1,925,000 | SH | SOLE | 1,925,000 | 0 | 0 | ||
KRONOS BIO INC | COM | 50107A104 | 12,229 | 583,436 | SH | SOLE | 583,436 | 0 | 0 | ||
908 DEVICES INC | COM | 65443P102 | 13,219 | 406,502 | SH | SOLE | 406,502 | 0 | 0 | ||
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 28,404 | 3,901,589 | SH | SOLE | 3,901,589 | 0 | 0 | ||
INVITAE CORP | COM | 46185L103 | 346,950 | 12,203,669 | SH | SOLE | 12,203,669 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 12,578 | 601,515 | SH | SOLE | 601,515 | 0 | 0 | ||
PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 204,161 | 7,990,652 | SH | SOLE | 7,990,652 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 115,670 | 3,668,574 | SH | SOLE | 3,668,574 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 77,028 | 2,800,000 | SH | SOLE | 2,800,000 | 0 | 0 | ||
SEER INC | COM CL A | 81578P106 | 5,180 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 22,932 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 101,728 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | ||
STOKE THERAPEUTICS INC | COM | 86150R107 | 3,053 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
TWIST BIOSCIENCE CORP | COM | 90184D100 | 106,970 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
ZAI LAB LTD | ADR | 98887Q104 | 20,024 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
DECIBEL THERAPEUTICS INC | COM | 24343R106 | 9,021 | 1,170,048 | SH | SOLE | 1,170,048 | 0 | 0 | ||
SANA BIOTECHNOLOGY INC | COM | 799566104 | 1,351 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
ORCHARD THERAPEUTICS PLC | ADS | 68570P101 | 5,923 | 2,575,000 | SH | SOLE | 2,575,000 | 0 | 0 | ||
ALPHA TEKNOVA INC | COM | 02080L102 | 7,467 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
CENTURY THERAPEUTICS INC | COM | 15673T100 | 80,673 | 3,206,380 | SH | SOLE | 3,206,380 | 0 | 0 | ||
MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | 21,408 | 960,883 | SH | SOLE | 960,883 | 0 | 0 | ||
RECURSION PHARMACEUTICALS IN | CL A | 75629V104 | 12,613 | 548,156 | SH | SOLE | 548,156 | 0 | 0 | ||
SINGULAR GENOMICS SYSTEMS IN | COM | 82933R100 | 30,133 | 2,692,870 | SH | SOLE | 2,692,870 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 142,794 | 3,038,167 | SH | SOLE | 3,038,167 | 0 | 0 | ||
NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 1,382 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
23ANDME HOLDING CO | CLASS A COM | 90138Q108 | 16,684 | 1,841,457 | SH | SOLE | 1,841,457 | 0 | 0 | ||
ABSCI CORPORATION | COM | 00091E109 | 89,767 | 7,718,593 | SH | SOLE | 7,718,593 | 0 | 0 | ||
MAXCYTE INC | COM | 57777K106 | 170,590 | 13,971,334 | SH | SOLE | 13,971,334 | 0 | 0 | ||
TENAYA THERAPEUTICS INC | COM | 87990A106 | 74,068 | 3,586,818 | SH | SOLE | 3,586,818 | 0 | 0 | ||
VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 9,070 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
SEMA4 HOLDINGS CORP | COM CL A | 81663L101 | 37,950 | 5,000,000 | SH | SOLE | 5,000,000 | 0 | 0 | ||
TANGO THERAPEUTICS INC | COM | 87583X109 | 70,959 | 5,487,910 | SH | SOLE | 5,487,910 | 0 | 0 | ||
SOMALOGIC INC | CLASS A COM | 83444K105 | 153,501 | 12,389,082 | SH | SOLE | 12,389,082 | 0 | 0 | ||
GINKGO BIOWORKS HOLDINGS INC | CL A SHS | 37611X100 | 83,481 | 7,202,808 | SH | SOLE | 7,202,808 | 0 | 0 |